How Did One Woman Change the FDA's Drug Approval Process?

How Did One Woman Change the FDA's Drug Appro...

Up next

How Can We Separate Ninja Fact from Ninja Fiction?

Over a few hundred years, real stories about secretive agents developed into the legend of the ninja. Learn how this myth captured the world's imagination -- and about the work being done at the world's first International Ninja Research Center -- in this episode of BrainStuff, b ...  Show more

How Did 'Bourgeois' Become a Bad Word?

The French word 'bourgeois' originally just meant a middle-class town dweller, but it's taken on a lot of different (and often derogatory) connotations over the centuries, including in the English slang term 'bougie'. Learn more in this episode of BrainStuff, based on this articl ...  Show more

Recommended Episodes

Ep 970 | How the FDA Removed ALL of the Safety Protocols in Developing the Shots | Guest: Dr. Jane Ruby
Conservative Review with Daniel Horowitz

It’s worse than you think. Dr. Jane Ruby, a scientist with over 20 years of experience in regulatory processes for drug approval with the FDA, explains several important ways that the FDA and the drug companies violated the most basic safety protocols at every stage of the develo ...  Show more

Why doesn't the FDA regulate herbal supplements?
Stuff You Should Know

For thousands of years, societies across the globe have used herbs as medicine. While this practice continues today, the FDA does not regulate these potent substances. Find out why the FDA can't regulate herbal supplements in this HowStuffWorks podcast.

Learn more ...  Show more

“Mini Brains” That Grew Eyes and How the FDA Saved Babies
Curiosity Weekly

Learn about stem cell “mini brains” that grew eyes and how the FDA prevented an epidemic of birth defects in the 1960s.Scientists grew stem cell 'mini brains' that developed mini-eyes on their own by Cameron DukeGabriel, E., Albanna, W., Pasquini, G., Ramani, A., Josipovic, N., M ...  Show more

The Abortion Pill Legal Standoff Endangers Access to All Drugs
Science, Spoken

A Fifth Circuit ruling that keeps mifepristone available, but curtails access to it, is the newest front in a battle over the FDA’s power to approve medications.   Read the story here.